IMMUNO-BIOLOGICAL LABORATORIES CO., LTD.

Highlights Immuno-Biological Laboratories Co., Ltd.

Equities

4570

JP3921300004

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-05-17 am EDT			5-day change	1st Jan Change
503 ^JPY	+1.21%		+6.34%	+2.03%

2023	Immuno-Biological Laboratories Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023	CI
2023	An unknown buyer agreed to acquire unknown minority stake in CURED Co., Ltd. from Immuno-Biological Laboratories Co., Ltd.	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Immuno-Biological Laboratories Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-12	CI
An unknown buyer agreed to acquire unknown minority stake in CURED Co., Ltd. from Immuno-Biological Laboratories Co., Ltd.	23-02-05	CI
An undisclosed buyer acquired 26.32% stake in Cell Remover Co., Ltd. from Immuno-Biological Laboratories Co., Ltd..	19-12-19	CI
Transgenic Inc. Enters into Joint Research Agreement with Immuno-Biological Laboratories Co. Ltd	17-06-27	CI
Hideki Egawa cancelled the acquisition of 79.6 % stake in M Cosmetics Co., Ltd. from Immuno-Biological Laboratories Co., Ltd., Mitsuru Onishi and others.	16-03-27	CI
Hideki Egawa signed a contract to acquire 79.6 % stake in M Cosmetics Co., Ltd. from Immuno-Biological Laboratories Co., Ltd., Mitsuru Onishi and others for ¥20.6 million.	15-03-27	CI
Xseed High Growth I managed by Japan Asia Investment Co. Ltd. acquired Skylight Biotech Inc.	14-12-30	CI
Astellas Pharma and Immuno-Biological Conclude Collaborative Research Agreement	13-12-31	CI
Immuno-Biological Laboratories Co., Ltd. completed the acquisition of 41.7% stake in Skylight Biotech Inc.	13-07-01	CI
Immuno-Biological Laboratories Co., Ltd. completed the acquisition of 58.3% stake in Skylight Biotech Inc. from a group of sellers.	13-06-20	CI
Immuno-Biological Laboratories Co., Ltd. agreed to acquire 41.7% stake in Skylight Biotech Inc. for approximately ¥150 million.	13-05-13	CI
Immuno-Biological Laboratories Co., Ltd. agreed to acquire 58.3% stake in Skylight Biotech Inc. from a group of sellers for approximately ¥160 million.	13-05-13	CI
Immuno-Biological Laboratories Co., Ltd. Signs Collaboration and License Agreement with IBL International GmbH	12-09-18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Stock Market
Equities
4570 Stock
News Immuno-Biological Laboratories Co., Ltd.
Highlights

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW